LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Harmony Biosciences Holdings Inc

Open

SectorHealthcare

36.11 1.32

Overview

Share price change

24h

Current

Min

35.53

Max

36.86

Key metrics

By Trading Economics

Income

11M

51M

Sales

39M

239M

P/E

Sector Avg

11.697

121.746

EPS

1.08

Profit margin

21.242

Employees

268

EBITDA

14M

73M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+27.43% upside

Dividends

By Dow Jones

Next Earnings

24 lut 2026

Market Stats

By TradingEconomics

Market Cap

448M

2.1B

Previous open

34.79

Previous close

36.11

News Sentiment

By Acuity

34%

66%

96 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 lut 2026, 23:57 UTC

Hot Stocks

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 lut 2026, 23:35 UTC

Earnings
Major Market Movers

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 lut 2026, 23:28 UTC

Earnings

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 lut 2026, 21:47 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 lut 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 lut 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 lut 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 lut 2026, 23:33 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 lut 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 lut 2026, 22:55 UTC

Earnings
Hot Stocks

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 lut 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 lut 2026, 22:23 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 lut 2026, 21:57 UTC

Earnings

XP 4Q Rev BRL4.95B >XP

12 lut 2026, 21:52 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 lut 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

12 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 lut 2026, 21:47 UTC

Earnings

Morningstar 4Q Rev $641M >MORN

12 lut 2026, 21:39 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 lut 2026, 21:38 UTC

Earnings

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

27.43% upside

12 Months Forecast

Average 47.25 USD  27.43%

High 55 USD

Low 42 USD

Based on 5 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Very Strong Bearish Evidence

Sentiment

By Acuity

96 / 352 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat